CHUNLI MEDICAL to Continue Engagement with Daxin Accounting Firm

Stock News
Apr 30

CHUNLI MEDICAL (01858) has announced a proposal to re-appoint Daxin Certified Public Accountants (Special General Partnership) as the company's financial and internal control auditor for the 2026 fiscal year. The decision, aimed at maintaining continuity and stability in the audit process, was recommended by the board's audit committee and received prior approval from all independent directors. The appointment period will commence from the date of the resolution passed at the 2025 annual general meeting and will conclude upon the holding of the 2026 annual general meeting. The board of directors will seek authorization from the shareholders' meeting for the management to finalize the specific remuneration with Daxin, taking into account the audit workload for 2026 and prevailing market rates.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10